iShares U.S. Pharmaceuticals ETF Rating $102.68 -0.31 (-0.30%) As of 01:55 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.72Holdings in IHE have an aggregate rating of Moderate Buy based on 349 analyst ratings issued in the past year covering 25 companies (91.7% of the portfolio).IHE Aggregate Price Target$101.96-0.45% DownsideHigh Prediction$101.96Average Prediction$101.96Low Prediction$101.96Holdings in IHE have an aggregate price target of $101.96 and a range of $101.96 to $101.96 covering 25 companies (91.7% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings21.95%JNJJohnson & Johnson$261.01-0.4%4.8074 of 5 stars2.80$268.22 2.8%25Trending News21.36%LLYEli Lilly and Company$1,182.33-2.2%4.7287 of 5 stars2.83$1,292.18 9.3%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision4.70%BMYBristol Myers Squibb$64.26-0.6%4.219 of 5 stars2.52$66.06 2.8%25Trending NewsAnalyst Revision4.39%MRKMerck & Co., Inc.$135.33-0.2%4.3446 of 5 stars2.68$135.50 0.1%22Trending NewsAnalyst ForecastInsider TradeAnalyst Revision4.28%RPRXRoyalty Pharma$58.65+0.2%4.3773 of 5 stars3.00$60.86 3.8%8Analyst Forecast4.18%VTRSViatris$16.19+0.9%2.5827 of 5 stars2.57$17.50 8.1%74.17%PFEPfizer$26.88+0.3%3.6971 of 5 stars2.19$28.28 5.2%21Trending NewsAnalyst Revision3.87%ZTSZoetis$74.16-2.2%4.7853 of 5 stars2.32$109.62 47.8%19Analyst Forecast3.55%JAZZJazz Pharmaceuticals$244.34-0.6%4.1011 of 5 stars2.95$272.89 11.7%20Analyst Forecast2.67%ELANElanco Animal Health$23.57+4.7%4.2934 of 5 stars2.77$29.09 23.4%13Insider Trade2.28%CORTCorcept Therapeutics$114.64+3.7%3.3707 of 5 stars2.63$119.17 3.9%8Positive NewsInsider Trade2.00%AXSMAxsome Therapeutics$215.40+0.8%3.2561 of 5 stars2.82$267.60 24.2%22Earnings ReportAnalyst Forecast1.95%CRNXCrinetics Pharmaceuticals$84.68+0.3%1.9518 of 5 stars2.24$81.00 -4.3%17Positive News1.38%LQDALiquidia$73.68+2.2%4.5367 of 5 stars2.64$98.08 33.1%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision1.33%LGNDLigand Pharmaceuticals$294.29+1.9%3.8248 of 5 stars3.00$336.57 14.4%9Positive NewsAnalyst Upgrade1.32%DFTXDefinium Therapeutics$42.44-3.3%3.0462 of 5 stars3.00$62.14 46.4%18Trending NewsAnalyst ForecastAnalyst RevisionGap Down1.04%INDVIndivior$38.92+1.8%4.0886 of 5 stars2.86$45.17 16.1%7Positive News0.79%OGNOrganon & Co.$13.720.0%1.5702 of 5 stars1.71$11.40 -16.9%7News Coverage0.74%EWTXEdgewise Therapeutics$43.66+1.1%2.1051 of 5 stars2.82$49.08 12.4%11Positive NewsAnalyst Forecast0.72%ELVNEnliven Therapeutics$58.43+0.6%3.2297 of 5 stars2.71$72.67 24.4%70.69%AMRXAmneal Pharmaceuticals$17.71+2.5%3.3188 of 5 stars3.00$17.67 -0.2%8Positive NewsAnalyst DowngradeInsider Trade0.60%SUPNSupernus Pharmaceuticals$48.03+1.9%4.2654 of 5 stars2.71$62.83 30.8%70.57%TARSTarsus Pharmaceuticals$69.39+0.7%3.1101 of 5 stars2.78$90.50 30.4%9Analyst ForecastAnalyst Revision0.57%PBHPrestige Consumer Healthcare$51.71+0.8%3.5348 of 5 stars2.17$70.75 36.8%60.55%NKTRNektar Therapeutics$74.26-2.2%2.8122 of 5 stars2.75$150.00 102.0%12Trending NewsEarnings Report This page (NYSEARCA:IHE) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...Behind the Markets | SponsoredCentral banks bought 710 tonnes - this fund pays monthlyGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWhy November 27 Is Quickly Becoming America's Most Important Financial Date in DecadesAn estimated $10 trillion could move through a little known government initiative, according to analyst Joel L...Altimetry | SponsoredLeading AI Insider Issues Urgent Market WarningA leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...TradeSmith | SponsoredGold buyout deals have handed shareholders overnight gains up to 79 percentGold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
